211 related articles for article (PubMed ID: 11487181)
1. Unawareness of dyskinesias in Parkinson's and Huntington's diseases.
Vitale C; Pellecchia MT; Grossi D; Fragassi N; Cuomo T; Di Maio L; Barone P
Neurol Sci; 2001 Feb; 22(1):105-6. PubMed ID: 11487181
[TBL] [Abstract][Full Text] [Related]
2. Self-awareness of motor dysfunction in patients with Huntington's disease in comparison to Parkinson's disease and cervical dystonia.
Sitek EJ; Sołtan W; Wieczorek D; Schinwelski M; Robowski P; Reilmann R; Guzińska K; Harciarek M; Krysa W; Sławek J
J Int Neuropsychol Soc; 2011 Sep; 17(5):788-95. PubMed ID: 21729402
[TBL] [Abstract][Full Text] [Related]
3. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.
Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C
Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091
[TBL] [Abstract][Full Text] [Related]
4. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
Fenney A; Jog MS; Duval C
Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
[TBL] [Abstract][Full Text] [Related]
5. Assessing self-awareness of dyskinesias in Parkinson's disease through movie materials.
Sitek EJ; Soltan W; Wieczorek D; Robowski P; Schinwelski M; Slawek J
Funct Neurol; 2011; 26(3):121-6. PubMed ID: 22152432
[TBL] [Abstract][Full Text] [Related]
6. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
Goetz CG; Damier P; Hicking C; Laska E; Müller T; Olanow CW; Rascol O; Russ H
Mov Disord; 2007 Jan; 22(2):179-86. PubMed ID: 17094088
[TBL] [Abstract][Full Text] [Related]
7. Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study.
Péchevis M; Clarke CE; Vieregge P; Khoshnood B; Deschaseaux-Voinet C; Berdeaux G; Ziegler M;
Eur J Neurol; 2005 Dec; 12(12):956-63. PubMed ID: 16324089
[TBL] [Abstract][Full Text] [Related]
8. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
[TBL] [Abstract][Full Text] [Related]
9. Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.
Aldaz T; Nigro P; Sánchez-Gómez A; Painous C; Planellas L; Santacruz P; Cámara A; Compta Y; Valldeoriola F; Martí MJ; Muñoz E
J Neurol; 2019 Jun; 266(6):1340-1350. PubMed ID: 30834978
[TBL] [Abstract][Full Text] [Related]
10. [Self-awareness of deficits in Huntington's and Parkinson's disease].
Sitek EJ; Sławek J; Wieczorek D
Psychiatr Pol; 2008; 42(3):393-403. PubMed ID: 19899567
[TBL] [Abstract][Full Text] [Related]
11. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
Svenningsson P; Rosenblad C; Af Edholm Arvidsson K; Wictorin K; Keywood C; Shankar B; Lowe DA; Björklund A; Widner H
Brain; 2015 Apr; 138(Pt 4):963-73. PubMed ID: 25669730
[TBL] [Abstract][Full Text] [Related]
12. Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: clinical features and mechanisms.
Pietracupa S; Fasano A; Fabbrini G; Sarchioto M; Bloise M; Latorre A; Altieri M; Bologna M; Berardelli A
Parkinsonism Relat Disord; 2013 Nov; 19(11):1004-8. PubMed ID: 23890762
[TBL] [Abstract][Full Text] [Related]
13. Self-awareness of executive dysfunction in Huntington's disease: comparison with Parkinson's disease and cervical dystonia.
Sitek EJ; Sołtan W; Wieczorek D; Schinwelski M; Robowski P; Harciarek M; Guzińska K; Sławek J
Psychiatry Clin Neurosci; 2013 Jan; 67(1):59-62. PubMed ID: 23331288
[TBL] [Abstract][Full Text] [Related]
14. Disability in Activities of Daily Living and Severity of Dyskinesias Determine the Handicap of Parkinson's Disease Patients in Advanced Stage Selected to DBS.
Coelho M; Abreu D; Correia-Guedes L; Lobo PP; Fabbri M; Godinho C; Domingos J; Albuquerque L; Freitas V; Pereira JM; Cattoni B; Carvalho H; Reimão S; Rosa MM; Ferreira AG; Ferreira JJ
J Parkinsons Dis; 2017; 7(2):255-261. PubMed ID: 28157106
[TBL] [Abstract][Full Text] [Related]
15. Inter-limb coupling during diadochokinesis in Parkinson's and Huntington's disease.
Daneault JF; Carignan B; Sadikot AF; Duval C
Neurosci Res; 2015 Aug; 97():60-8. PubMed ID: 25747139
[TBL] [Abstract][Full Text] [Related]
16. Self-unawareness of levodopa induced dyskinesias in patients with Parkinson's disease.
Amanzio M; Palermo S; Zibetti M; Leotta D; Rosato R; Geminiani G; Lopiano L
Brain Cogn; 2014 Oct; 90():135-41. PubMed ID: 25058494
[TBL] [Abstract][Full Text] [Related]
17. Unawareness of motor phenoconversion in Huntington disease.
McCusker EA; Gunn DG; Epping EA; Loy CT; Radford K; Griffith J; Mills JA; Long JD; Paulsen JS;
Neurology; 2013 Sep; 81(13):1141-7. PubMed ID: 23966256
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
19. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease.
Hurelbrink CB; Lewis SJ; Barker RA
J Neurol; 2005 Jun; 252(6):642-7. PubMed ID: 15742112
[TBL] [Abstract][Full Text] [Related]
20. Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.
Liu X; Carroll CB; Wang SY; Zajicek J; Bain PG
J Neurosci Methods; 2005 May; 144(1):47-52. PubMed ID: 15848238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
